Ursodeoxycholic Acid at 18–22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis
Aim. To compare the response between the current recommended dosage 13–15 mg/kg/d and 20 mg/kg/d dose of ursodeoxycholic acid (UDCA) in primary biliary cholangitis (PBC) patients who do not respond completely to a standard dose of UDCA. Methods. We included 73 patients with poor response and randomi...
Saved in:
Main Authors: | Xinyu Xiang, Xiaoli Yang, Mengyi Shen, Chen Huang, Yifeng Liu, Xiaoli Fan, Li Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2021/6691425 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 in Patients with Primary Biliary Cholangitis
by: М. К. Prashnova, et al.
Published: (2022-09-01) -
Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
by: Satoru Joshita, et al.
Published: (2017-01-01) -
Time to Make the Change from ‘Primary Biliary Cirrhosis’ to ‘Primary Biliary Cholangitis’
by: Angela C Cheung, et al.
Published: (2015-01-01) -
Results of non-interventional observational study of ursodeoxycholic acid in primary biliary cirrhosis
by: Yelena N. Shirokova, et al.
Published: (2018-08-01) -
Rare renal proximal tubular dysfunctions in primary biliary cholangitis
by: Xiaoxiao Shi, et al.
Published: (2024-12-01)